LIFE SCIENCES
Accelerating innovation from discovery to patient impact
Scientific innovation is transforming medicine at an unprecedented pace. As therapies grow more complex and markets more competitive, organizations must make faster, smarter, and more confident strategic decisions. NOVA Partners helps biopharmaceutical, biotechnology, medical-technology, diagnostics, and CDMO organizations — and the investors who back them — navigate that complexity by combining scientific expertise, strategic insight, and disciplined execution.
Who we serve
Biopharmaceutical companies
Biotechnology companies
Medical device and diagnostics companies
Contract development and manufacturing organizations (CDMOs)
Healthcare investors and private equity
Government and economic-development organizations
How we help
Private Capital & Value Creation
We help private-equity and venture-capital firms make better investment decisions — from target screening and rigorous scientific and commercial due diligence to 100-day value-creation plans, exit strategy, and ongoing portfolio transformation.
R&D Portfolio Strategy & IND Readiness
We help biopharma and MedTech organizations sharpen R&D strategy and accelerate pipeline progression — prioritizing high-potential assets, building target product profiles, and preparing organizations for IND submission and first-in-human trials.
Transformation & Operational Excellence
We help organizations strengthen their operational foundations — process redesign, cost optimization, capacity expansion, and digital transformation — building the resilient, AI-enabled operating models needed to compete.
Commercial & Go-to-Market Strategy
We help leadership teams design and execute global commercial strategies that translate scientific innovation into sustainable growth — from market landscaping and launch planning to omnichannel HCP engagement and pricing, access, and reimbursement strategy.
Medical Affairs
We help organizations build high-performing medical organizations through scientific engagement, evidence generation, field-medical strategy, and publication planning.
AI & Advanced Analytics
We help clients apply artificial intelligence and advanced analytics to improve forecasting, commercial decision-making, medical insight, and operational efficiency.
Representative challenges we solve
- Preparing a first commercial launch
- Scaling a growing biotechnology company
- Prioritizing R&D investment across a portfolio
- Evaluating licensing and partnership opportunities
- Building medical-affairs capabilities
- Supporting private-equity due diligence
- Designing AI-enabled operating models
Why NOVA Partners
Our professionals bring experience across consulting, biomedical engineering, medicine, scientific research, commercialization, and executive leadership. We understand the realities of developing innovative therapies because we have worked alongside the organizations creating them — combining scientific depth with business strategy to move clients from breakthrough ideas to measurable results.
